MedTrace Logo

SNIFF 120: Study of Nasal Insulin to Fight Forgetfulness (120 Days)

NCT00438568 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 173

Last updated 2012-09-14

No results posted yet for this study

Summary

The purpose of this study is to find out if insulin, when administered as a "nasal spray" into the nasal passages, improves memory in adults with mild cognitive impairment (MCI) or Alzheimer's disease.

Conditions

Interventions

DRUG

Regular Insulin

administered intra-nasally twice a day for 16 weeks

DRUG

Placebo

administered intra-nasally twice a day for 16 weeks

Sponsors & Collaborators

Principal Investigators

  • Suzanne Craft, PhD · University of Washington

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
55 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2006-06-30
Primary Completion
2011-12-31
Completion
2011-12-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Drugs
Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00438568 on ClinicalTrials.gov